Our Science & Technology
At Cardiol, we think medicine should work better. To improve the quality of life for people living with heart failure, we are developing innovative nanotherapeutics that target anti-inflammatory drugs, including cannabidiol, to inflamed tissue in the heart.
Our proprietary nanotherapeutics are designed to increase the compatibility of drugs with the aqueous blood circulation, improve pharmacokinetics, and facilitate drug accumulation in the failing heart.
Cardiol is also pursuing an immunotherapeutics program commencing with an innovative cancer immunotherapeutic in combination with cannabinoids for Glioblastoma Multiforme (GBM), a Fast Track eligible Orphan Indication and commercializing a line of pharmaceutically-manufactured pure cannabidiol products to address the growing market for medical cannabinoids.